Alembic Pharmaceuticals (NSE:APLLTD) Quality Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:APLLTD Alembic Pharmaceuticals Ltd NSE:APLLTD
77 GF Score
Price ₹797.60
GF Value ₹1,055.95
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Alembic Pharmaceuticals Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

Alembic Pharmaceuticals Quality Rank Related Terms

NSE:APLLTD
77GF Score
Alembic Pharmaceuticals Ltd NSE:APLLTD
Quality Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Alembic Pharmaceuticals (NSE:APLLTD) Overvalued in 2026?

Based on GuruFocus' analysis, Alembic Pharmaceuticals stock appears to be undervalued. The current stock price of ₹797.60 is trading 24.5% below its estimated GF Value™ of ₹1,055.95. GuruFocus considers Alembic Pharmaceuticals to be Modestly Undervalued.

Key valuation signals for NSE:APLLTD:

  • Quality Rank:
  • GF Value™: ₹1,055.95 vs. price of ₹797.60 (24.5% below fair value)
  • GF Score™: 77/100 with 3 warning signs

No single metric tells the full story. See the NSE:APLLTD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alembic Pharmaceuticals Business Description

Other Exchanges 533573:India
Address Alembic Road, Vadodara, GJ, IND, 390 003
Alembic Pharmaceuticals Ltd is a specialty and generic drug manufacturing company. The company focuses on manufacturing and marketing generic pharmaceutical products across the globe. Alembic also operates a branded formulation business that covers a range of therapeutic areas such as dermatology, oncology, ophthalmology, and injectable formulations. The company considers merger and acquisition investment as a potential component of its operational growth for expanding its research, development, manufacturing, and marketing capabilities.
77GF Score

Get the complete analysis for NSE:APLLTD

Quality Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹797.60
Price
₹1,055.95
GF Value